Our Solutions
Strategic & Potential Research Sites in Indonesia
*Will be updated in a timely manner
Site Transformation Journey
Gaps in SOPs, QMS, contracting & staff capability limit readiness for international multi-centre trials.
A structured diagnostic maps the precise distance between your current state and global trial-readiness across ICH GCP domains.
A multimodal program: classroom, mentorship & expert immersion abroad covering the all pillars of trial-ready infrastructure.
ICH GCP-aligned. Unified SOPs. Functioning QMS. Trained staff. Patient-centred culture. Ready for immediate activation with Nusa Trials studies.
Selected site champions undergo international expert immersion, then return to certify and cascade learning across all Indonesian partner sites.
Research that Moves Indonesia Forward
For Sponsors
- Indonesia offers a large and highly motivated patient population across a wide range of therapeutic areas.
- Nusa Trials provides ICH-GCP-compliant site management from feasibility through close-out.
- We combine global operational standards with local expertise and cost efficiency.
Our growing network of GCP-trained sites across Jakarta reduces start-up timelines and increases enrolment predictability
For Sites & Healthcare Professionals
- Nusa Trials supports investigators with full site management, training, and regulatory guidance.
- We invest in building long-term research capacity at Indonesian sites.
- Joining our network means access to international trials, structured capacity building, and a professional research infrastructure.
For Patients & Communities
- Clinical trials at Nusa Trials sites provide access to innovative treatments not yet commercially available.
- We ensure ethical and and standardized participation.
- Nusa Trials is committed to culturally sensitive, respectful engagement with all communities.
